Giorgia Colarossi, Filippo Migliorini, Michael Becker, Jessica P Arias, Ruediger Autschbach, Ajay Moza, Ali Aljalloud
{"title":"Conventional Prostheses versus Sutureless Perceval for Aortic Valve Replacement: A Meta-Analysis.","authors":"Giorgia Colarossi, Filippo Migliorini, Michael Becker, Jessica P Arias, Ruediger Autschbach, Ajay Moza, Ali Aljalloud","doi":"10.5761/atcs.ra.22-00125","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>Perceval sutureless valves have gained popularity. Whether this implant performs superior to the traditional sutured prosthesis remains unclear. This meta- analysis compared the Perceval implants versus the sutured conventional valves for aortic valve replacement (AVR).</p><p><strong>Methods: </strong>This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The following databases were accessed: PubMed, Google Scholar, Web of Science, Scopus, and EMBASE. All clinical investigations comparing Perceval versus the conventional prostheses for AVR were considered.</p><p><strong>Results: </strong>The Perceval group demonstrated higher rate of pacemaker implantation (P <0.00001). Aortic cross-clamp (ACC) time (P <0.00001) and cardiopulmonary bypass (CPB) time (P <0.00001) were shorter in the Perceval group. Similarity was found in mean and peak pressure gradient (P = 0.8 and P = 0.2, respectively), mean aortic valve area (P = 0.3), length of intensive care unit (P = 0.4) and hospital stay (P = 0.2), rate of revision (P = 0.11), hemorrhages (P = 0.05), paravalvular leak (P = 0.3), cerebrovascular complication (P = 0.7), and early mortality (P = 0.06).</p><p><strong>Conclusion: </strong>Given the shorter ACC time and CPB time, Perceval AVR can be an alternative in high-risk patients. The higher rate of pacemaker implantation following Perceval may limit its routine implantation.</p>","PeriodicalId":8037,"journal":{"name":"Annals of Thoracic and Cardiovascular Surgery","volume":"29 3","pages":"107-124"},"PeriodicalIF":1.1000,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2c/d2/atcs-29-107.PMC10284666.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Thoracic and Cardiovascular Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5761/atcs.ra.22-00125","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 2
Abstract
Purpose: Perceval sutureless valves have gained popularity. Whether this implant performs superior to the traditional sutured prosthesis remains unclear. This meta- analysis compared the Perceval implants versus the sutured conventional valves for aortic valve replacement (AVR).
Methods: This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. The following databases were accessed: PubMed, Google Scholar, Web of Science, Scopus, and EMBASE. All clinical investigations comparing Perceval versus the conventional prostheses for AVR were considered.
Results: The Perceval group demonstrated higher rate of pacemaker implantation (P <0.00001). Aortic cross-clamp (ACC) time (P <0.00001) and cardiopulmonary bypass (CPB) time (P <0.00001) were shorter in the Perceval group. Similarity was found in mean and peak pressure gradient (P = 0.8 and P = 0.2, respectively), mean aortic valve area (P = 0.3), length of intensive care unit (P = 0.4) and hospital stay (P = 0.2), rate of revision (P = 0.11), hemorrhages (P = 0.05), paravalvular leak (P = 0.3), cerebrovascular complication (P = 0.7), and early mortality (P = 0.06).
Conclusion: Given the shorter ACC time and CPB time, Perceval AVR can be an alternative in high-risk patients. The higher rate of pacemaker implantation following Perceval may limit its routine implantation.
目的:穿刺无缝合线瓣膜已得到广泛应用。这种假体是否优于传统的缝合假体尚不清楚。这项荟萃分析比较了Perceval植入物与缝合的传统主动脉瓣置换术(AVR)。方法:本荟萃分析按照系统评价和荟萃分析指南的首选报告项目进行。访问了以下数据库:PubMed、Google Scholar、Web of Science、Scopus和EMBASE。所有比较Perceval与传统假体治疗AVR的临床研究都被考虑在内。结果:Perceval组起搏器植入率较高(P)。结论:鉴于ACC时间和CPB时间较短,Perceval AVR可作为高危患者的替代选择。珀西瓦尔术后起搏器植入率较高,可能限制其常规植入率。